Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS‐CoV‐2 mRNA vaccination
Sebastian J. Theobald(University of Cologne), Jan Rybniker(University of Cologne), Ulrike Göbel(University of Cologne), Alexander Simonis(University of Cologne), Viktoria Kohlhas(Düsseldorf University Hospital), Manuel Koch(University of Cologne), Sandra Winter(University of Cologne), Julie M Mudler(University of Cologne), Michael Hallek(University of Cologne), Marie‐Christine Albert(University of Cologne), Phuong‐Hien Nguyen(University of Cologne), Henning Walczak(University of Cologne), Richard Acton(Babraham Institute), Anna‐Maria Hellmann(University of Cologne), Jakob J Malin(University of Cologne)
Cited by 21
Related Papers
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
|Blood|2018|1.7k
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k